Gastroenterology and Hepatology

Episodes 17-17 of 17

• 

  RestartResume

  What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?

  RestartResume

  What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?

  MinuteCE®

  What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?

  1.25 program credits

  • 

    

    Yelena Janjigian, MD

  1.25 program credits

• Previous
• 1
• 2
• Next